225 related articles for article (PubMed ID: 24001049)
1. Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy.
Draman MS; Grennan-Jones F; Zhang L; Taylor PN; Tun TK; McDermott J; Moriarty P; Morris D; Lane C; Sreenan S; Dayan C; Ludgate M
Thyroid; 2013 Dec; 23(12):1600-8. PubMed ID: 24001049
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin F2α Regulates Adipogenesis by Modulating Extracellular Signal-Regulated Kinase Signaling in Graves' Ophthalmopathy.
Zhu R; Wang XH; Wang BW; Ouyang X; You YY; Xie HT; Zhang MC; Jiang FG
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108173
[TBL] [Abstract][Full Text] [Related]
3. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
Guo Y; Li H; Chen X; Yang H; Guan H; He X; Chen Y; Pokharel S; Xiao H; Li Y
J Clin Endocrinol Metab; 2020 Jun; 105(6):1906-17. PubMed ID: 32249902
[TBL] [Abstract][Full Text] [Related]
4. Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an
Wang X; Yang S; Ye H; Chen J; Shi L; Feng L; Wang X; Zhang T; Chen R; Xiao W; Yang H
Thyroid; 2022 Mar; 32(3):294-305. PubMed ID: 34605662
[No Abstract] [Full Text] [Related]
5. Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
Han YE; Hwang S; Kim JH; Byun JW; Yoon JS; Lee EJ
Thyroid; 2018 Apr; 28(4):528-536. PubMed ID: 29589999
[TBL] [Abstract][Full Text] [Related]
6. 4-Methylumbelliferone suppresses hyaluronan and adipogenesis in primary cultured orbital fibroblasts from Graves' orbitopathy.
Yoon Y; Chae MK; Lee EJ; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1095-1102. PubMed ID: 31900640
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoke extract-induced adipogenesis in Graves' orbital fibroblasts is inhibited by quercetin via reduction in oxidative stress.
Yoon JS; Lee HJ; Chae MK; Lee SY; Lee EJ
J Endocrinol; 2013 Feb; 216(2):145-56. PubMed ID: 23143154
[TBL] [Abstract][Full Text] [Related]
8. Wnt signalling inhibits adipogenesis in orbital fibroblasts from patients with Graves' orbitopathy.
Jung SJ; Choi YJ; Park TK; Woo SE; Kim BY; Yoon JS; Jang SY
Br J Ophthalmol; 2022 Jul; 106(7):1019-1027. PubMed ID: 34193409
[TBL] [Abstract][Full Text] [Related]
9. AZD1208, a pan-Pim kinase inhibitor, inhibits adipogenesis and induces lipolysis in 3T3-L1 adipocytes.
Park YK; Obiang-Obounou BW; Lee KB; Choi JS; Jang BC
J Cell Mol Med; 2018 Apr; 22(4):2488-2497. PubMed ID: 29441719
[TBL] [Abstract][Full Text] [Related]
10. Adipogenic and Lipolytic Effects of Ascorbic Acid in Ovariectomized Rats.
Kim B; Choi KM; Yim HS; Park HT; Yim JH; Lee MG
Yonsei Med J; 2018 Jan; 59(1):85-91. PubMed ID: 29214781
[TBL] [Abstract][Full Text] [Related]
11. Syringic acid (4-hydroxy-3,5-dimethoxybenzoic acid) inhibits adipogenesis and promotes lipolysis in 3T3-L1 adipocytes.
John CM; Arockiasamy S
Nat Prod Res; 2020 Dec; 34(23):3432-3436. PubMed ID: 30777451
[TBL] [Abstract][Full Text] [Related]
12. The Role of Sphingosine-1-Phosphate in Adipogenesis of Graves' Orbitopathy.
Kim SE; Lee JH; Chae MK; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):301-11. PubMed ID: 26830367
[TBL] [Abstract][Full Text] [Related]
13. Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype.
Kuriyan AE; Woeller CF; O'Loughlin CW; Phipps RP; Feldon SE
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7370-7. PubMed ID: 24135759
[TBL] [Abstract][Full Text] [Related]
14. Anti-obesity effects of kaempferol by inhibiting adipogenesis and increasing lipolysis in 3T3-L1 cells.
Torres-Villarreal D; Camacho A; Castro H; Ortiz-Lopez R; de la Garza AL
J Physiol Biochem; 2019 Feb; 75(1):83-88. PubMed ID: 30539499
[TBL] [Abstract][Full Text] [Related]
15. Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells.
Yamamoto Y; Taniguchi T; Inazumi T; Iwamura R; Yoneda K; Odani-Kawabata N; Matsugi T; Sugimoto Y; Shams NK
J Ocul Pharmacol Ther; 2020 Apr; 36(3):162-169. PubMed ID: 31934812
[No Abstract] [Full Text] [Related]
16. Anti-oxidative and anti-adipogenic effects of caffeine in an in vitro model of Graves' orbitopathy.
Ko J; Kim JY; Kim JW; Yoon JS
Endocr J; 2020 Apr; 67(4):439-447. PubMed ID: 31941844
[TBL] [Abstract][Full Text] [Related]
17. APPL1 knockdown blocks adipogenic differentiation and promotes adipocyte lipolysis.
Wen Z; Tang Z; Li M; Zhang Y; Li J; Cao Y; Zhang D; Fu Y; Wang C
Mol Cell Endocrinol; 2020 Apr; 506():110755. PubMed ID: 32045627
[TBL] [Abstract][Full Text] [Related]
18. Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves' Orbitopathy.
Schrijver B; Kooiman MA; Kasteleijn E; van Holten-Neelen C; Virakul S; Paridaens D; Peeters RP; van Hagen PM; Dalm VASH; Dik WA
Thyroid; 2019 Mar; 29(3):395-404. PubMed ID: 30724135
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D decreases adipocyte lipid storage and increases NAD-SIRT1 pathway in 3T3-L1 adipocytes.
Chang E; Kim Y
Nutrition; 2016 Jun; 32(6):702-8. PubMed ID: 26899162
[TBL] [Abstract][Full Text] [Related]
20. PERK mediates oxidative stress and adipogenesis in Graves' orbitopathy pathogenesis.
Ko J; Kim JY; Kyoung Chae M; Jig Lee E; Sook Yoon J
J Mol Endocrinol; 2021 May; 66(4):313-323. PubMed ID: 33870911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
